Global University Venturing

Suono Bio is based on MIT research and is aiming to use low-frequency ultrasound to bring therapeutic compounds to target cells with greater efficiency.

Ngaio Merrick has been on the commercialisation initiative's board since 2016, having previously worked with a municipal development agency.

BennuBio has assumed control of an existing UNM licence for cytometer technology, securing commitments from three investors to target a commercial release by next year.

Allied Minds has backed a series B round for its portfolio company BridgeSat, which also welcomed Boeing HorizonX Ventures as an investor.

Suat Topsu, a professor at University of Paris-Saclay, has been appointed president of Satt IDF Innov, one of France’s regional tech transfer organisations.

University of Queensland revealed it has generated more than 100 spinouts since 1988, with probiotic drink manufacturer Perkii becoming number 100 in 2016.

Twentyeight-Seven Therapeutics has officially launched with $65m in series A funding to commercialise oncology treatments based on research at Harvard Medical School.

Sentea has been spun out with $1.9m in seed funding to commercialise fibre optic sensor technologies that monitor engineering structures for wear and damage.

Logistics data analytics platform Locix has emerged from stealth with $20m in funding provided by investors including University of Tokyo Edge Capital.

A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

Abigail Barrow will stand down as interim executive director of University of Massachusetts's office of technology commercialization on September 14 after three and a half years.